Related references
Note: Only part of the references are listed.Diffuse large B-cell lymphoma-treatment approaches in the molecular era
Mark Roschewski et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib
Girija Dasmahapatra et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
MicroRNA-26a Suppresses Tumor Growth and Metastasis of Human Hepatocellular Carcinoma by Targeting Interleukin-6-Stat3 Pathway
Xin Yang et al.
HEPATOLOGY (2013)
miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
Min Deng et al.
PLOS ONE (2013)
CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression
Qian Liang et al.
SCIENTIFIC REPORTS (2013)
Level of cdk5 expression predicts the survival of relapsed multiple myeloma patients
Zachary Levacque et al.
CELL CYCLE (2012)
Going out of the brain: Non-nervous system physiological and pathological functions of Cdk5
Erick Contreras-Vallejos et al.
CELLULAR SIGNALLING (2012)
MicroRNA-26a Promotes Cholangiocarcinoma Growth by Activating β-catenin
Jinqiang Zhang et al.
GASTROENTEROLOGY (2012)
Achaete-scute homologue-1 (ASH1) stimulates migration of lung cancer cells through Cdk5/p35 pathway
Abeba Demelash et al.
MOLECULAR BIOLOGY OF THE CELL (2012)
DNA methylation and microRNA dysregulation in cancer
Hiromu Suzuki et al.
MOLECULAR ONCOLOGY (2012)
Blocking Autophagy Prevents Bortezomib-Induced NF-κB Activation by Reducing I-κBα Degradation in Lymphoma Cells
Li Jia et al.
PLOS ONE (2012)
MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2
Juan Lu et al.
CANCER RESEARCH (2011)
Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer
Bo Zhang et al.
CARCINOGENESIS (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Cell-Based High-Content Screening Assay Reveals Activators and Inhibitors of Cancer Cell Invasion
Manuela Quintavalle et al.
SCIENCE SIGNALING (2011)
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphoma
Violetta V. Leshchenko et al.
BLOOD (2010)
Inhibiting the Cyclin-Dependent Kinase CDK5 Blocks Pancreatic Cancer Formation and Progression through the Suppression of Ras-Ral Signaling
Georg Feldmann et al.
CANCER RESEARCH (2010)
The cdk5 Kinase Regulates the STAT3 Transcription Factor to Prevent DNA Damage upon Topoisomerase I Inhibition
Sandy Courapied et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro
Manuela Quintavalle et al.
JOURNAL OF CELL BIOLOGY (2010)
The Proapoptotic Function of Noxa in Human Leukemia Cells Is Regulated by the Kinase Cdk5 and by Glucose
Xazmin H. Lowman et al.
MOLECULAR CELL (2010)
The transcriptional network for mesenchymal transformation of brain tumours
Maria Stella Carro et al.
NATURE (2010)
Reciprocal Regulation of MicroRNA-1 and Insulin-Like Growth Factor-1 Signal Transduction Cascade in Cardiac and Skeletal Muscle in Physiological and Pathological Conditions
Leonardo Elia et al.
CIRCULATION (2009)
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo
Jason T. Huse et al.
GENES & DEVELOPMENT (2009)
Cyclin I activates Cdk5 and regulates expression of Bcl-2 and Bcl-XL in postmitotic mouse cells
Paul T. Brinkkoetter et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death
Bo Tian et al.
NATURE CELL BIOLOGY (2009)
Causes and consequences of microRNA dysregulation in cancer
Carlo M. Croce
NATURE REVIEWS GENETICS (2009)
Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion
Ren Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The 3′ untranslated region of human Cyclin-Dependent Kinase 5 Regulatory subunit I contains regulatory elements affecting transcript stability
Silvia Moncini et al.
BMC MOLECULAR BIOLOGY (2007)
p53 downstream target genes and tumor suppression: a classical view in evolution
L. M. Rozan et al.
CELL DEATH AND DIFFERENTIATION (2007)
Cyclin-dependent kinase 5 activity controls cell motility and metastatic potential of prostate cancer cells
Christopher J. Strock et al.
CANCER RESEARCH (2006)
Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity
AKY Fu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Share Paper
